Our leadership team comprises people of extraordinary accomplishment; many hold multiple advanced degrees and have decades of experience working in the medical device industry. This team fosters the most forward-thinking culture in clinical research. Meet the genae Management Team.
CEOFirst appointed: 2005
Together with Aly Talen and private investors, he then founded genae, a global mid-size CRO with focus on medical devices. He currently rolls-out a merger and acquisition plan for the genae group and continues to expand the offices in the USA, Europe, the Middle East and Asia Pacific. January 2015 marked the integration of e-novex in the e-Solutions business unit of the genae Group.
Sr. VP Business DevelopmentFirst appointed: 2005
Aly lived and worked in different countries which facilitates in the contact with different cultures. Her experience and network in the clinical field make her a credible and reliable partner in discussions with key opinion leaders and the medical industries. She is a talented communicator with a strong clinical research background.
Aly is all about providing clear and full support to customers, resulting in long-lasting relationships and repeat business opportunities.
Jörn O. BalzerMD, MHBA
CMOFirst appointed: 2016
He holds a PhD in Diagnostic Radiology and a Master in Health Business Administration.
He teaches Radiology at the J.W. Goethe University in Frankfurt and is specialized in Interventional Radiology, MRT and CT.
CTOFirst appointed: 2010
In 2008, Peter co-founded e-novex, a services provider for clinical trials with Electronic Data Collection and Clinical Trial Management System technologies. In 2010, he co-founded Techsoft, an ICT consultancy.
COOFirst appointed: 2011
He then joined Terumo as a Product Specialist for Central and Eastern Europe where he later became the Clinical Research Coordinator for the Nobori I DES trial; the first multi-center, randomized trial for Terumo.
Wouter was Country Manager for the UK and Ireland at Spectranetics International where he established a direct sales organization.
Wouter’s profound clinical knowledge and expertise has led to his recognition as a respected communication partner by many key opinion leaders worldwide.
President genae AmericasFirst appointed: 2014
Philippe was then a Sr. Associate at GE’s leadership program, Corporate Audit Staff. His assignments in healthcare, oil & gas, real estate and financial services have led him to be posted in North America, the Middle East, North Africa and Eastern Europe.
Philippe’s in-depth expertize and knowledge of business processes, financial audits and transaction analysis are tremendous assets to complement the growth of the global genae group.
Ask the expert
Please submit your question